Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management
While both medications contain the same active ingredient (tirzepatide), they are approved for different therapeutic indications and may have different dosing regimens
Visceral fat reduction specifically may reach 25-35% based on imaging studies
Peel and press firmly onto skin
Together, they act on distinct but complementary receptor pathways to amplify pulsatile GH release
US$ 28.33
US$ 28.00
US$ 20.85
US$ 21.75
